Pathophysiology, Biomarkers, and Therapeutic Modalities Associated with Skeletal Muscle Loss Following Spinal Cord Injury

被引：7

作者：

P. Drasites, Kelsey ^{[1
,2
,3
]}

Shams, Ramsha ^{[1
,2
,3
]}

Zaman, Vandana ^{[1
,4
]}

Matzelle, Denise ^{[1
,4
]}

C. Shields, Donald ^{[1
]}

P. Garner, Dena ^{[3
]}

J. Sole, Christopher ^{[3
]}

Haque, Azizul ^{[2
]}

Banik, Narendra L. ^{[1
,2
,4
]}

机构：

[1] Med Univ South Carolina, Dept Neurosurg, 96 Jonathan Lucas St, Charleston, SC 29425 USA

[2] Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave, Charleston, SC 29425 USA

[3] Citadel, Dept Hlth & Human Performance, 171 Moultrie St, Charleston, SC 29409 USA

[4] Ralph H Johnson Vet Adm Med Ctr, 109 Bee St, Charleston, SC 29401 USA

来源：

BRAIN SCIENCES | 2020年 / 10卷 / 12期

关键词：

muscle atrophy; calpain; inflammation; estrogen; biomarkers; neuroprotection; CLINICAL-PRACTICE; CALPAIN-I; ESTROGEN; ATROPHY; NEURONS; REGENERATION; REPLACEMENT; ACTIVATION; MECHANISMS; APOPTOSIS;

D O I：

10.3390/brainsci10120933

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

A spinal cord injury (SCI) may lead to loss of strength, sensation, locomotion and other body functions distal to the lesion site. Individuals with SCI also develop secondary conditions due to the lack of skeletal muscle activity. As SCI case numbers increase, recent studies have attempted to determine the best options to salvage affected musculature before it is lost. These approaches include pharmacotherapeutic options, immunosuppressants, physical activity or a combination thereof. Associated biomarkers are increasingly used to determine if these treatments aid in the protection and reconstruction of affected musculature.

引用

页码：1 / 13

页数：13

共 50 条

[1] Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
Lima, Rui
Monteiro, Andreia
Salgado, Antonio J.
Monteiro, Susana
Silva, Nuno A.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
[2] Bone and muscle loss after spinal cord injury: organ interactions
Qin, Weiping
Bauman, William A.
Cardozo, Christopher
MOLECULAR AND INTEGRATIVE PHYSIOLOGY OF THE MUSCULOSKELETAL SYSTEM, 2010, 1211 : 66 - 84
[3] Current therapeutic strategies for inflammation following traumatic spinal cord injury
Priyanka L.Singh
Nitin Agarwal
James C.Barrese
Robert F.Heary
NeuralRegenerationResearch, 2012, 7 (23) : 1812 - 1821
[4] Current therapeutic strategies for inflammation following traumatic spinal cord injury
Singh, Priyanka L.
Agarwal, Nitin
Barrese, James C.
Heary, Robert F.
NEURAL REGENERATION RESEARCH, 2012, 7 (23) : 1812 - 1821
[5] Identification of immunodiagnostic blood biomarkers associated with spinal cord injury severity
Li, Jianfeng
Liu, Xizhe
Wang, Jianmin
Wang, Fuan
Zhu, Zhengya
Tang, Tao
Wang, Jun
Zhou, Zhiyu
Gao, Manman
Liu, Shaoyu
FRONTIERS IN IMMUNOLOGY, 2023, 14
[6] Pathophysiology and treatment of spinal cord injury
Privat, A
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (06): : 1109 - 1117
[7] Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota
Pagan-Rivera, Luis H.
Ocasio-Rivera, Samuel E.
Godoy-Vitorino, Filipa
Miranda, Jorge D.
FRONTIERS IN MICROBIOLOGY, 2024, 15
[8] Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury
Thakore, Nakul P.
Samantaray, Supriti
Park, Sookyoung
Nozaki, Kenkichi
Smith, Joshua A.
Cox, April
Krause, James
Banik, Naren L.
NEUROCHEMICAL RESEARCH, 2016, 41 (1-2) : 44 - 52
[9] Pathophysiology of Spinal Cord Injury
Hachem, Laureen D.
Fehlings, Michael G.
NEUROSURGERY CLINICS OF NORTH AMERICA, 2021, 32 (03) : 305 - 313
[10] Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors
Ray, SK
Hogan, EL
Banik, NL
BRAIN RESEARCH REVIEWS, 2003, 42 (02) : 169 - 185

← 1 2 3 4 5 →